Dopamine-deficient mice are hypersensitive to dopamine receptor agonists

J Neurosci. 2000 Jun 15;20(12):4405-13. doi: 10.1523/JNEUROSCI.20-12-04405.2000.

Abstract

Dopamine-deficient (DA-/-) mice were created by targeted inactivation of the tyrosine hydroxylase gene in dopaminergic neurons. The locomotor activity response of these mutants to dopamine D1 or D2 receptor agonists and l-3,4-dihydroxyphenylalanine (l-DOPA) was 3- to 13-fold greater than the response elicited from wild-type mice. The enhanced sensitivity of DA-/- mice to agonists was independent of changes in steady-state levels of dopamine receptors and the presynaptic dopamine transporter as measured by ligand binding. The acute behavioral response of DA-/- mice to a dopamine D1 receptor agonist was correlated with c-fos induction in the striatum, a brain nucleus that receives dense dopaminergic input. Chronic replacement of dopamine to DA-/- mice by repeated l-DOPA administration over 4 d relieved the hypersensitivity of DA-/- mutants in terms of induction of both locomotion and striatal c-fos expression. The results suggest that the chronic presence of dopaminergic neurotransmission is required to dampen the intracellular signaling response of striatal neurons.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Autoradiography
  • Benzamides / pharmacokinetics
  • Brain / drug effects
  • Brain / metabolism*
  • Carrier Proteins / metabolism*
  • Cocaine / analogs & derivatives
  • Cocaine / pharmacokinetics
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dopamine / deficiency*
  • Dopamine Agonists / pharmacology*
  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine beta-Hydroxylase / genetics
  • Dopamine beta-Hydroxylase / metabolism*
  • Iodine Radioisotopes
  • Levodopa / pharmacology*
  • Membrane Glycoproteins*
  • Membrane Transport Proteins*
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Motor Activity / drug effects*
  • Nerve Tissue Proteins*
  • Pyrrolidines / pharmacokinetics
  • Receptors, Dopamine / metabolism*
  • Tyrosine 3-Monooxygenase / deficiency
  • Tyrosine 3-Monooxygenase / genetics
  • Tyrosine 3-Monooxygenase / metabolism*

Substances

  • Benzamides
  • Carrier Proteins
  • Dopamine Agonists
  • Dopamine Plasma Membrane Transport Proteins
  • Iodine Radioisotopes
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Pyrrolidines
  • Receptors, Dopamine
  • epidepride
  • RTI 121
  • Levodopa
  • Tyrosine 3-Monooxygenase
  • Dopamine beta-Hydroxylase
  • Cocaine
  • Dopamine